Device / Technology News

RSS

Intel expands availability of Intel Health Guide across Europe

Intel is expanding availability of the Intel Health Guide across Europe to help address chronic care challenges - Intel is working with strategic partners in France, Germany, Spain and The Netherlands to bring localised versions of the Intel Health Guide to market over the coming year

26 May 2010

Alliance Technologies integrates PacketSure Managed DLP platform to provide Data Loss Prevention solution

Palisade Systems, the leader in Data Loss Prevention solutions for the small and medium-sized enterprise, said today that Alliance Technologies has integrated the PacketSure Managed DLP platform to provide a Data Loss Prevention solution engineered for large, shared network environments. Alliance Technologies becomes one of the growing number of managed service providers to offer PacketSure Managed DLP to its customers.

26 May 2010

Abbott reports positive 6-month results from bioresorbable vascular scaffold trial at EuroPCR 2010

Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).

26 May 2010

Physicians able to retrieve medical evidence from smartphones

Global scientific, technical, medical and scholarly publisher Wiley-Blackwell today announced the that its evidence-based clinical decision support product, Essential Evidence Plus, is now accessible from mobile devices. Physicians on the move can now easily find answers to challenging point-of-care questions from their iPhoneTM, IPod Touch-, AndroidTM, Blackberry- or other Smartphones.

26 May 2010

Medtronic’s Resolute zotarolimus-eluting stent as effective as Xience V everolimus-eluting stent: Study

The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR meeting. In this novel 2,292-patient randomized trial, the Resolute zotarolimus-eluting stent from Medtronic, Inc. was found to be as safe and effective as the Xience® V everolimus-eluting stent from Abbott Laboratories.

26 May 2010

InspireMD announces next generation MGuard Prime net protective Cobalt Chromium stent system

InspireMD, Ltd. announced today the next generation MGuard stent, MGuard Prime(R), a net protective Cobalt Chromium stent system. MGuard Prime(R) offers an advanced patented Cobalt Chromium design, superior flexibility and excellent deliverability on top of the established benefits of the MGuard MicroNet(R) technology.

26 May 2010

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.

26 May 2010

Carolina Conceptions receives IRB approval to study on new egg freezing technology

Carolina Conceptions, an infertility practice in Raleigh, NC, announces IRB approval to commence a study on egg freezing - a newer technology that is growing in demand. While embryo and sperm freezing have been the standard of care for decades, egg freezing has been slower to achieve the same level of success.

26 May 2010

ifp Institut für Produktqualität sells molecular biological, PCR-based food test product line to QIAGEN

The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.

From QIAGEN Manchester Limited 26 May 2010

SunTech Medical's clinical-grade blood pressure technology selected for new Portable PFS

SunTech Medical, a leading manufacturer of blood pressure monitors and OEM non-invasive blood pressure modules, is pleased to announce the selection of their clinical-grade blood pressure technology for the new Portable Pulmonary Function System by Damec.

26 May 2010

Consequences of secrecy in medicine

No one knows how many mothers' and babies' lives have been saved by the obstetrical forceps. This device has been part of the standard equipment of every maternity room for about 250 years. However, a shadow lies over the success story: after the Chamberlen brothers developed the device at the beginning of the 17th century, the brothers and their descendants used it for 3 generations, but kept it a secret from other obstetricians.

26 May 2010

Researchers use CASL MRI technique to map cerebral blood flow patterns in schizophrenic patients

Researchers in Germany have used a magnetic resonance imaging technique called continuous arterial spin labeling to map cerebral blood flow patterns in schizophrenic patients quickly and without using radiation or contrast agents. Their findings appear in the online edition and July printed issue of the journal Radiology.

26 May 2010

PIONEER trial evaluates new safe concept of stent-drug combination

Blue Medical today announced a major step forward in its quest to improve the quality of life of patients with cardiovascular disease, with the start of the PIONEER trial, in which a new safe concept of stent-drug combination is evaluated.

26 May 2010

Intelerad Medical Systems announces InteleOne contract with ALR

Intelerad Medical Systems, a recognized leader in medical imaging PACS and workflow solutions, today announced an InteleOne contract with Alliance Radiology, P.A. InteleOne will allow ALR to deliver superior reading and reporting services by consolidating workflow for multiple imaging clients into a unified worklist.

26 May 2010

MedMira obtains NHS Supply Chain listing for Reveal Rapid HIV Test in the UK

MedMira Inc., a developer of rapid diagnostic technology and solutions, today announced that the Company's Reveal Rapid HIV Test is now one of three rapid HIV tests listed by the National Health Services Supply Chain in the United Kingdom, and the only one able to address both point of care and laboratory testing requirements.

26 May 2010

Boston Scientific initiates study to compare PROMUS Element Stent to XIENCE PRIME Stent System

Boston Scientific Corporation today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS® Element™ Everolimus-Eluting Coronary Stent System to the XIENCE PRIME™ Everolimus-Eluting Coronary Stent System.

26 May 2010

Accenture announces enhanced insurance industry solutions

Accenture has unveiled newly enhanced claims and policy administration solutions designed to help property and casualty (P&C) and life insurers focus on operational efficiency and profitable growth by enhancing process automation and multi-channel distribution integration.

26 May 2010

Study confirms effectiveness of CT for diagnosis of appendicitis

When CT results suggest appendicitis, but a patient's symptoms are inconsistent with the acute condition, physicians should consider a diagnosis of chronic or recurrent appendicitis and surgical treatment, according to a new study published in the online edition and July printed issue of the journal Radiology.

26 May 2010

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

At 12 months the NEVO™ Sirolimus-eluting Coronary Stent has continued to demonstrate excellent safety and efficacy outcomes compared to Taxus® Liberte® according to new data presented today from the NEVO™ RES-I clinical trial. These results were presented as a late breaking trial at EuroPCR, the leading medical conference in Europe for physicians specializing in interventional cardiovascular medicine.

26 May 2010

$FDA warns on possible fracture risk with proton pump inhibitors use$

FDA warns on possible fracture risk with proton pump inhibitors use

The U.S. Food and Drug Administration today warned consumers and health care professionals about a possible increased risk of fractures of the hip, wrist, and spine with high doses or long-term use of a class of medications called proton pump inhibitors. The product labeling will be changed to describe this possible increased risk.

26 May 2010

Device / Technology News

Intel expands availability of Intel Health Guide across Europe

Alliance Technologies integrates PacketSure Managed DLP platform to provide Data Loss Prevention solution

Abbott reports positive 6-month results from bioresorbable vascular scaffold trial at EuroPCR 2010

Physicians able to retrieve medical evidence from smartphones

Medtronic’s Resolute zotarolimus-eluting stent as effective as Xience V everolimus-eluting stent: Study

InspireMD announces next generation MGuard Prime net protective Cobalt Chromium stent system

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

Carolina Conceptions receives IRB approval to study on new egg freezing technology

ifp Institut für Produktqualität sells molecular biological, PCR-based food test product line to QIAGEN

SunTech Medical's clinical-grade blood pressure technology selected for new Portable PFS

Consequences of secrecy in medicine

Researchers use CASL MRI technique to map cerebral blood flow patterns in schizophrenic patients

PIONEER trial evaluates new safe concept of stent-drug combination

Intelerad Medical Systems announces InteleOne contract with ALR

MedMira obtains NHS Supply Chain listing for Reveal Rapid HIV Test in the UK

Boston Scientific initiates study to compare PROMUS Element Stent to XIENCE PRIME Stent System

Accenture announces enhanced insurance industry solutions

Study confirms effectiveness of CT for diagnosis of appendicitis

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

FDA warns on possible fracture risk with proton pump inhibitors use

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News